Document Detail


Looking to the future: a new decade of pulmonary arterial hypertension therapy.
MedLine Citation:
PMID:  22130819     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Pulmonary arterial hypertension (PAH) is a severe and debilitating disease characterised by vascular proliferation and remodelling of the small pulmonary arteries, leading to a progressive increase in pulmonary vascular resistance, increased afterload on the right ventricle and, ultimately, right heart failure. Although there is no "cure" for PAH, the availability of targeted therapies over the past decade has led to major advances in the management of PAH, reflected in improvements in survival in the modern treatment era. However, despite this, disease progression is inevitable in the majority of patients with PAH and overall the long-term prognosis, although improved, remains poor. There is a clear and urgent need for new therapeutic options, either through the development of improved drugs that act on targets established by existing PAH-specific therapies, or of agents targeting novel pathogenic pathways not addressed by currently available therapies. A number of such new agents that have shown promise in experimental models and preliminary human studies are discussed in this article.
Authors:
V V McLaughlin
Related Documents :
22029999 - Pulmonary hypertension in sickle cell disease.
18290889 - Aortic valve replacement with simultaneous chest wall reconstruction for radiation-indu...
1097839 - Consturction of new right ventricle on the epicardium: a possible correction for underd...
10196619 - Ureter and bladder replacement following radical cystectomy.
3586709 - Polyether-urethane elastomers for small-diameter arterial prostheses.
8522569 - A long term follow-up of one of the first arterial homografts.
16572089 - Management of carotid restenosis.
12106779 - Lack of prejunctional modulation of noradrenaline release by endogenous nitric oxide in...
16556879 - Evidence for involvement of both ikca and skca channels in hyperpolarizing responses of...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European respiratory review : an official journal of the European Respiratory Society     Volume:  20     ISSN:  1600-0617     ISO Abbreviation:  Eur Respir Rev     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111391     Medline TA:  Eur Respir Rev     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  262-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Optimal management of severe pulmonary arterial hypertension.
Next Document:  Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and...